The 2018 proxy season proved challenging for some technology and life sciences companies, as Institutional Shareholder Services (ISS) issued more negative Say-on-Pay voting recommendations. As a result, companies saw lower average shareholder support levels. This marks a shift from patterns observed since 2015, where Say-on-Pay results have generally improved from year to year.